Search

Your search keyword '"Sadler, Ross"' showing total 244 results

Search Constraints

Start Over You searched for: Author "Sadler, Ross" Remove constraint Author: "Sadler, Ross" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
244 results on '"Sadler, Ross"'

Search Results

2. 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

8. Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination.

9. Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination

10. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services.

11. Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia

14. P-378 Longitudinal antibody and T-cell kinetics over four doses of COVID-19 vaccination and predictors of poor response in patients with multiple myeloma

15. Environmental and Human Health Hazards from Chlorpyrifos, Pymetrozine and Avermectin Application in China under a Climate Change Scenario: A Comprehensive Review

17. The role of the G protein in the pathogenesis of RSV

24. Exposure Routes and Health Risks Associated with Pesticide Application

25. The Terrestrial Reptiles of Australia's Island Territories [1983]

28. Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response

29. Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response

32. COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma

37. Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic

39. Epidemiology of soil-transmitted helminth infections in Semarang, Central Java, Indonesia

40. Maintenance therapy with infliximab or vedolizumab in inflammatory bowel disease is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic

43. COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma.

44. A multi-disciplinary approach to igG4 related disease aids in diagnosis and management

45. Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease

49. PTU-100 The role of a multi-regional specialist multi-disciplinary meeting in diagnosis and management of igg4-related disease

Catalog

Books, media, physical & digital resources